ArticleVeterinary research communications2026
Protective effects of rosmarinic acid against carbaryl-exposed toxicity in honey bees (Apis mellifera): histopathological and molecular docking evidence.
Article in Veterinary research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to evaluate the potential protective role of Rosmarinic acid (RA) against Carbaryl (CRB)-induced toxicity in honey bees by assessing survival, nutrient uptake, and intestinal tissue integrity , while exploring potential CYP-mediated detoxification mechanisms via complementary in silico modelling. Honey bees were divided into six experimental groups: CRB-1, CRB-2, CRB-1 + RA, CRB-2 + RA, RA-only, and control, and treatments were administered for three days. Results showed a 100% mortality rate in the groups treated with high doses of CRB alone or in combination with RA. In contrast, the addition of RA to the low-dose CRB group resulted in surviving individuals, with a statistically significant increase in survival rate compared to the pesticide-only group (p < 0.05), while RA supplementation in the high-dose CRB group delayed mortality despite complete lethality. Food consumption decreased significantly only in the CRB-2 group; however, RA co-treatment during the first two days effectively mitigated this reduction. Histopathological examination showed severe damage to the intestinal epithelium in CRB-treated groups, while co-treatment with RA significantly reduced the severity of these low-dose pesticide-induced lesions. Furthermore, in silico molecular modelling and docking analyses suggested that RA may interact with detoxification-related cytochrome P450 enzymes in honey bees, providing preliminary computational insight into possible associations with CYP-mediated phase I metabolism. Collectively, these findings indicate that Rosmarinic acid improves physiological resilience in honey bees under Carbaryl-induced xenobiotic stress, with in silico data suggesting a potential link to detoxification pathways.
Indexed as
Identifiers
42696195What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.